Table 3 Efficacy of colchicine on the duration of COVID-19 illness till recovery
From: The role of colchicine in the management of COVID-19: a Meta-analysis
Study | Type of study | Median duration of illness Colchicine vs control | P-value |
|---|---|---|---|
Lopes et al. 2021 | RCT | 7.0 vs 9.0 | 0.003 |
Sandhu et al. 2020 | NRCT | 10.5 vs 11 | 0.947 |
Mareev et al. 2021 | NRCT | 13.0 vs 17.5 | 0.079 |